PTPN2, a potential therapeutic target for type 1 diabetes?

被引：2
|
作者：
Liu, Shan-Shan [1 ]
Lou, Ji-Quan [1 ]
Ding, Ye [1 ]
机构：
[1] Shanghai Pudong Inst Hlth Dev, Dept Hlth Evaluat, Shanghai, Peoples R China
来源：
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 2014年 / 58卷 / 09期
关键词：
BETA-CELL APOPTOSIS; CANDIDATE GENE;
D O I：
10.1590/0004-2730000003561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：978 / 979
页数：2
相关论文
共 50 条
  • [31] The HIV latency reversing agent HODHBt inhibits the phosphatases PTPN1 and PTPN2
    Howard, J. Natalie
    Zaikos, Thomas D.
    Levinger, Callie
    Rivera, Esteban
    McMahon, Elyse K.
    Holmberg, Carissa S.
    Terao, Joshua
    Sanz, Marta
    Copertino Jr, Dennis C.
    Wang, Weisheng
    Soriano-Sarabia, Natalia
    Jones, R. Brad
    Bosque, Alberto
    JCI INSIGHT, 2024, 9 (18)
  • [32] Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death
    Arturo Roca-Rivada
    Sandra Marín-Cañas
    Maikel L. Colli
    Chiara Vinci
    Toshiaki Sawatani
    Lorella Marselli
    Miriam Cnop
    Piero Marchetti
    Decio L. Eizirik
    Diabetologia, 2023, 66 : 1544 - 1556
  • [33] Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death
    Roca-Rivada, Arturo
    Marin-Canas, Sandra
    Colli, Maikel L.
    Vinci, Chiara
    Sawatani, Toshiaki
    Marselli, Lorella
    Cnop, Miriam
    Marchetti, Piero
    Eizirik, Decio L.
    DIABETOLOGIA, 2023, 66 (08) : 1544 - 1556
  • [34] The potential of PTPN22 as a therapeutic target for rheumatoid arthritis
    Carmona, F. David
    Martin, Javier
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (10) : 879 - 891
  • [35] Matriptase as a potential biomarker and therapeutic target in newly diagnosed type 2 diabetes mellitus
    Ismail Demir
    Ismail Yilmaz
    Ersan Horoz
    Bulent Calik
    Oktay Bilgir
    Irish Journal of Medical Science (1971 -), 2024, 193 : 223 - 230
  • [36] Matriptase as a potential biomarker and therapeutic target in newly diagnosed type 2 diabetes mellitus
    Demir, Ismail
    Yilmaz, Ismail
    Horoz, Ersan
    Calik, Bulent
    Bilgir, Oktay
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 (01) : 223 - 230
  • [37] The type 1 diabetes candidate genes PTPN2 and BACH2 cooperate for the modulation of the JAK/STAT and MAPKs pathways in human beta cells
    Roca-Rivada, A.
    Martin-Vazquez, E.
    Oliveira, J. G.
    Brachene, A. Coomans de
    Zimath, P. L.
    Costa-Junior, J. M.
    Eizirik, D. L.
    DIABETOLOGIA, 2024, 67 : S196 - S197
  • [38] The rs1893217 (T/C) polymorphism in PTPN2 gene is not associated with type 1 diabetes mellitus in subjects from Southern Brazil
    Rheinheimer, Jakeline
    de Oliveira, Fernanda dos Santos
    Canani, Luis Henrique
    Crispim, Daisy
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (04) : 382 - 388
  • [39] SIRT1: a promising therapeutic target in type 2 diabetes mellitus
    Mihanfar, Ainaz
    Akbarzadeh, Maryam
    Darband, Saber Ghazizadeh
    Sadighparvar, Shirin
    Majidinia, Maryam
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2024, 130 (01) : 13 - 28
  • [40] SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
    Kitada, Munehiro
    Koya, Daisuke
    DIABETES & METABOLISM JOURNAL, 2013, 37 (05) : 315 - 325
12345